New Delhi: Reddy Laboratory on Tuesday reported a 36 percent decline in consolidated net profit at Rs 380.4 Crore for the quarter ended June 30 2021, because of higher costs.
Major pharmacy has posted Rs 594.6 Crore’s net profit in the appropriate period a year ago.
The total income during the June quarter of the fiscal year reached Rs 5,053 Crore, up 12 percent by opposing Rs 4,513.6 Crore in the period of the years, Dr.
Reddy’s laboratory said in submission to BSE.
The total cost during the period reviewed was at 4.513.8, up 24.7 percent with Rs 3,620.8 Crore in the first fiscal first quarter.
Dr Reddy’s laboratory shares traded 4.15 percent lower at Rs 5,184.40 respectively at BSE.
Dr. Reddy’s advantage fell 36% to RS 380.4 Crore in the June quarter
